Following the success of “Oppenheimer,” famend director Christopher Nolan has reportedly joined forces with actor Matt Damon for a brand new IMAX Corp IMAX movie.
What Occurred: Nolan, who bagged an Oscar for “Oppenheimer,” is returning to Common Photos, which is owned by the Comcast Company CMCSA for his upcoming venture, reported Deadline, citing sources.
The movie is about for an IMAX launch on July 17, 2026, and taking pictures might begin in early 2025.
This would be the third collaboration between Damon and Nolan, following “Interstellar” and “Oppenheimer.”
Nolan is thought for his tendency to reteam with actors, and Damon joins Christian Bale and Cillian Murphy within the record of actors who have labored with Nolan on a number of events.
With the venture now formally underway, it’s anticipated to draw a number of A-list expertise to affix Damon within the ensemble forged, the report famous.
Why It Issues: Nolan’s determination to proceed with Common is no surprise, contemplating the success of “Oppenheimer.”
The movie raked in $328.9 million domestically and $975.6 million worldwide, bagging seven Oscars together with Greatest Image and Greatest Director.
“Oppenheimer” considerably contributed to Comcast’s third-quarter monetary yr 2023 income progress. The corporate reportedly income progress reaching $30.12 billion, surpassing the anticipated $29.69 billion on the time.
Peacock, a streaming service owned by NBCUniversal, a subsidiary of Comcast, reported an nearly 80% year-over-year improve, reaching 28 million. The platform’s income surged by 64%, hitting $830 million throughout the identical time.
Equally, IMAX’s third-quarter incomes in monetary yr 2023 was additionally pushed by the success of Oppenheimer.
On the time, IMAX reported a 51% year-over-year improve in gross sales, reaching $103.90 million, surpassing the analyst consensus of $100.72 million.
The film firm additionally famous that the third quarter was its second-highest-grossing quarter ever on the IMAX international field workplace.
Learn Subsequent:
Disclaimer: This content material was partially produced with the assistance of Benzinga Neuro and was reviewed and revealed by Benzinga editors.
Picture By way of Shutterstock
Market Information and Knowledge dropped at you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
